Title |
Bacteriophage Procurement for Therapeutic Purposes
|
---|---|
Published in |
Frontiers in Microbiology, August 2016
|
DOI | 10.3389/fmicb.2016.01177 |
Pubmed ID | |
Authors |
Beata Weber-Dąbrowska, Ewa Jończyk-Matysiak, Maciej Żaczek, Małgorzata Łobocka, Marzanna Łusiak-Szelachowska, Andrzej Górski |
Abstract |
Bacteriophages (phages), discovered 100 years ago, are able to infect and destroy only bacterial cells. In the current crisis of antibiotic efficacy, phage therapy is considered as a supplementary or even alternative therapeutic approach. Evolution of multidrug-resistant and pandrug-resistant bacterial strains poses a real threat, so it is extremely important to have the possibility to isolate new phages for therapeutic purposes. Our phage laboratory and therapy center has extensive experience with phage isolation, characterization, and therapeutic application. In this article we present current progress in bacteriophages isolation and use for therapeutic purposes, our experience in this field and its practical implications for phage therapy. We attempt to summarize the state of the art: properties of phages, the methods for their isolation, criteria of phage selection for therapeutic purposes and limitations of their use. Perspectives for the use of genetically engineered phages to specifically target bacterial virulence-associated genes are also briefly presented. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 20% |
France | 1 | 20% |
Germany | 1 | 20% |
Switzerland | 1 | 20% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Scientists | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | <1% |
Nepal | 1 | <1% |
Poland | 1 | <1% |
Unknown | 369 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 60 | 16% |
Student > Bachelor | 60 | 16% |
Student > Master | 49 | 13% |
Researcher | 29 | 8% |
Student > Doctoral Student | 18 | 5% |
Other | 54 | 14% |
Unknown | 103 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 70 | 19% |
Biochemistry, Genetics and Molecular Biology | 61 | 16% |
Immunology and Microbiology | 56 | 15% |
Medicine and Dentistry | 21 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 8 | 2% |
Other | 31 | 8% |
Unknown | 126 | 34% |